[Driving capacity and antidepressive drugs]

Area of Science:

• Psychopharmacology
• Neuroscience
• Traffic Safety

Background:

• Antidepressant medications are widely prescribed for depression.
• Depression itself can impair cognitive and psychomotor functions essential for driving.
• The impact of different antidepressant classes on driving ability requires further investigation.

Purpose of the Study:

• To evaluate the effects of antidepressant treatment on psychomotor performance relevant to driving.
• To compare the influence of newer antidepressants versus tricyclic antidepressants on driving-related abilities.

Main Methods:

• Sixty-four depressive inpatients were assessed under steady-state plasma drug levels.
• The Act and React Testsystem (ART 90) measured visual perception, reactivity, stress tolerance, selective attention, and vigilance.
• Data were analyzed based on medication type, illness severity, and patient age.

Main Results:

• A significant majority (76.2%) of patients did not meet the performance criteria of normal controls.
• Patients treated with newer antidepressants demonstrated superior psychomotor performance compared to those on tricyclic antidepressants.
• Performance was analyzed in relation to medication, depression severity, and age.

Conclusions:

• Depressive patients often exhibit impaired psychomotor function, affecting driving safety.
• Newer antidepressants appear to have more favorable effects on psychomotor function than tricyclic antidepressants.
• Systematic assessment of driving ability is crucial for depressive patients undergoing pharmacological treatment.